Potential Biotechnological Applications of Venoms from the Viperidae Family in Central America for Thrombosis
Authors:
- Jorge Eduardo Chang EstradaJEJorge Eduardo Chang Estrada
- Taissa Nunes GuerreroTGTaissa Nunes Guerrero
- Daniel Fernando Reyes-EnríquezDRDaniel Fernando Reyes-Enríquez
- Erica Santos NardyENErica Santos Nardy
- Roseane Guimarães FerreiraRFRoseane Guimarães Ferreira
- Cristian José Ruiz CalderónCCCristian José Ruiz Calderón
- Irmgardt A. WellmannIWIrmgardt A. Wellmann
- Kaio Murilo Monteiro EspíndolaKEKaio Murilo Monteiro Espíndola
- Alejandro Ferraz Do PradoAlejandro Ferraz Do Prado
- Andreimar Martins SoaresAndreimar Martins Soares
- Marcos Roberto de Mattos FontesMFMarcos Roberto de Mattos Fontes
- Marta Chagas MonteiroMMMarta Chagas Monteiro
Open Access
Abstract
Central America is home to one of the most abundant herpetofauna in the Americas, occupying only 7% of the continent’s total area. Vipers and lizards are among the most relevant venomous animals in medical practice due to the consequences of envenomation from the bite of these animals. A great diversity of biomolecules with immense therapeutic and biotechnological value is contained in their venom. This paper describes the prominent leading representatives of the family Viperidae, emphasizing their morphology, distribution, habitat, feeding, and venom composition, as well as the biotechnological application of some isolated components from the venom of the animals from these families, focusing on molecules with potential anti-thrombotic action. We present the leading protein families that interfere with blood clotting, platelet activity, or the endothelium pro-thrombotic profile. In conclusion, Central America is an endemic region of venomous animals that can provide many molecules for biotechnological applications.Keywords
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/200.963/2021, 308376/2020-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (E-26/200.963/2021, 308376/2020-0)
This publication has 198 references indexed in Scilit:
- Snake venomics. Strategy and applicationsJournal of Mass Spectrometry, 2007
- Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venomsCell Biochemistry and Function, 2005
- Inhibition of Prothrombin Activation by Bothrojaracin, a C-Type Lectin from Bothrops jararaca VenomArchives of Biochemistry and Biophysics, 2000
- Distinct Contributions of Glycoprotein VI and α2β1 Integrin to the Induction of Platelet Protein Tyrosine Phosphorylation and AggregationArchives of Biochemistry and Biophysics, 2000
- Purification, Characterization, and cDNA Cloning of a New Fibrinogenlytic Venom Protein, Agkisacutacin, from Agkistrodon acutus VenomBiochemical and Biophysical Research Communications, 1999
- Allosteric Changes of Thrombin Catalytic Site Induced by Interaction of Bothrojaracin with Anion-Binding Exosites I and IIBiochemical and Biophysical Research Communications, 1999
- Crystal Structure of Myotoxin II, a Monomeric Lys49-Phospholipase A2 Homologue Isolated from the Venom of Cerrophidion (Bothrops) godmaniArchives of Biochemistry and Biophysics, 1999
- Snakes, the evolution of mystery in natureIntegrative Biology: Issues, News, and Reviews, 1998
- cDNA Cloning of IX/X-BP, a Heterogeneous Two-Chain Anticoagulant Protein from Snake VenomBiochemical and Biophysical Research Communications, 1996
- Primary Structure of a Coagulant Enzyme, Bilineobin, from Agkistrodon bilineatus VenomArchives of Biochemistry and Biophysics, 1995